Literature DB >> 17974614

Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder.

A Rossi1, R Biancheri, F Zara, C Bruno, G Uziel, M S van der Knaap, C Minetti, P Tortori-Donati.   

Abstract

BACKGROUND AND
PURPOSE: Hypomyelination and congenital cataract (HCC) is an autosomal recessive white matter disease caused by deficiency of hyccin, a membrane protein implicated in both central and peripheral myelination. We aimed to describe the neuroimaging features of this novel entity.
MATERIALS AND METHODS: A systematic analysis of patients with unclassified leukoencephalopathies admitted to our institutions revealed 10 children with congenital cataract, slowly progressive neurologic impairment, and diffuse white matter abnormalities on neuroimaging. Psychomotor developmental delay was evident after the first year of life. Peripheral neuropathy was demonstrated by neurophysiologic studies in 9 children. The available neuroimaging studies were retrospectively reviewed.
RESULTS: In all patients, neuroimaging revealed diffuse involvement of the supratentorial white matter associated with preservation of both cortical and deep gray matter structures. Supratentorial white matter hypomyelination was detected in all patients; 7 patients also had evidence of variably extensive areas of increased white matter water content. Deep cerebellar white matter hypomyelination was found in 6 patients. Older patients had evidence of white matter bulk loss and gliosis. Proton MR spectroscopy showed variable findings, depending on the stage of the disease. Sural nerve biopsy revealed hypomyelinated nerve fibers. Mutations in the DRCTNNB1A gene on chromosome 7p15.3, causing complete or severe deficiency of hyccin, were demonstrated in all patients.
CONCLUSIONS: HCC is characterized by a combined pattern of primary myelin deficiency and secondary neurodegenerative changes. In the proper clinical setting, recognition of suggestive neuroimaging findings should prompt appropriate genetic investigations.

Entities:  

Mesh:

Year:  2007        PMID: 17974614      PMCID: PMC8118974          DOI: 10.3174/ajnr.A0792

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.

Authors:  F A Hanefeld; K Brockmann; P J W Pouwels; B Wilken; J Frahm; P Dechent
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

3.  A new leukoencephalopathy with vanishing white matter.

Authors:  M S van der Knaap; P G Barth; F J Gabreëls; E Franzoni; J H Begeer; H Stroink; J J Rotteveel; J Valk
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach.

Authors:  M S van der Knaap; S N Breiter; S Naidu; A A Hart; J Valk
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

5.  Canavan disease: CT and MR imaging of the brain.

Authors:  J Brismar; G Brismar; G Gascon; P Ozand
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

6.  New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum.

Authors:  Marjo S van der Knaap; SakkuBai Naidu; Petra J W Pouwels; Simona Bonavita; Rudy van Coster; Lieven Lagae; Jürgen Sperner; Robert Surtees; Raphael Schiffmann; Jakob Valk
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

7.  Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model.

Authors:  M N Degaonkar; M Khubchandhani; J K Dhawan; R Jayasundar; N R Jagannathan
Journal:  NMR Biomed       Date:  2002-06       Impact factor: 4.044

8.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

9.  Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract.

Authors:  Federico Zara; Roberta Biancheri; Claudio Bruno; Laura Bordo; Stefania Assereto; Elisabetta Gazzerro; Federica Sotgia; Xiao Bo Wang; Stefania Gianotti; Silvia Stringara; Marina Pedemonte; Graziella Uziel; Andrea Rossi; Angelo Schenone; Paolo Tortori-Donati; Marjo S van der Knaap; Michael P Lisanti; Carlo Minetti
Journal:  Nat Genet       Date:  2006-09-03       Impact factor: 38.330

10.  Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders.

Authors:  M Di Rocco; A Rossi; G Parenti; A E M Allegri; M Filocamo; A Pessagno; P Tortori-Donati; C Minetti; R Biancheri
Journal:  Neuropediatrics       Date:  2005-08       Impact factor: 1.947

View more
  9 in total

1.  Cockayne syndrome: a diffusion tensor imaging and volumetric study.

Authors:  Mériam Koob; François Rousseau; Vincent Laugel; Nicolas Meyer; Jean-Paul Armspach; Nadine Girard; Jean-Louis Dietemann
Journal:  Br J Radiol       Date:  2016-09-19       Impact factor: 3.039

2.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

3.  Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.

Authors:  Daniella Magen; Costa Georgopoulos; Peter Bross; Debbie Ang; Yardena Segev; Dorit Goldsher; Alexandra Nemirovski; Eli Shahar; Sarit Ravid; Anthony Luder; Bayan Heno; Ruth Gershoni-Baruch; Karl Skorecki; Hanna Mandel
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

4.  Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS.

Authors:  Carlos R Ferreira; Molly H Silber; Taeun Chang; Jonathan G Murnick; Brian Kirmse
Journal:  JIMD Rep       Date:  2015-11-05

Review 5.  Neurometabolic diseases of childhood.

Authors:  Zoltan Patay; Susan I Blaser; Andrea Poretti; Thierry A G M Huisman
Journal:  Pediatr Radiol       Date:  2015-09-07

6.  Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein.

Authors:  Elisabetta Gazzerro; Simona Baldassari; Caterina Giacomini; Veronica Musante; Floriana Fruscione; Veronica La Padula; Roberta Biancheri; Sonia Scarfì; Valeria Prada; Federica Sotgia; Ian D Duncan; Federico Zara; Hauke B Werner; Michael P Lisanti; Lucilla Nobbio; Anna Corradi; Carlo Minetti
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

Review 7.  The chemistry and biology of phosphatidylinositol 4-phosphate at the plasma membrane.

Authors:  Alex G Batrouni; Jeremy M Baskin
Journal:  Bioorg Med Chem       Date:  2021-05-01       Impact factor: 3.461

8.  Cognitive Impairment and Brain Imaging Characteristics of Patients with Congenital Cataracts, Facial Dysmorphism, Neuropathy Syndrome.

Authors:  Teodora Chamova; Dora Zlatareva; Margarita Raycheva; Stoyan Bichev; Luba Kalaydjieva; Ivailo Tournev
Journal:  Behav Neurol       Date:  2015-04-28       Impact factor: 3.342

9.  Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.

Authors:  Hiroshi Doi; Masao Ushiyama; Takashi Baba; Katsuko Tani; Masaaki Shiina; Kazuhiro Ogata; Satoko Miyatake; Yoko Fukuda-Yuzawa; Shoji Tsuji; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Shu-ichi Ikeda; Fumiaki Tanaka; Naomichi Matsumoto; Kunihiro Yoshida
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.